Skip to main content
Top
Published in: Rheumatology International 8/2016

01-08-2016 | Cases with a Message

A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease?

Authors: Pandiarajan Vignesh, Sagar Bhattad, Manphool Singhal, Surjit Singh

Published in: Rheumatology International | Issue 8/2016

Login to get access

Abstract

Epidemiological case definition of Kawasaki disease (KD) by the American Heart Association requires the presence of fever and four of the following: eye signs, oral mucosal changes, skin rashes, limb edema, and unilateral cervical lymphadenopathy. Incomplete KD is a well-known entity where there is lack of some of mucocutaneous features, and this occurs more often in infants. We report a 5-year-old boy with KD and giant coronary aneurysms, who presented only with fever and there is complete lack of skin and mucosal manifestations at presentation.
Literature
5.
go back to reference Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110(17):2747–2771. doi:10.1161/01.CIR.0000145143.19711.78 CrossRefPubMed Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110(17):2747–2771. doi:10.​1161/​01.​CIR.​0000145143.​19711.​78 CrossRefPubMed
6.
go back to reference Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, Lee J (2013) Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr 172(3):343–349. doi:10.1007/s00431-012-1891-5 CrossRefPubMed Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, Lee J (2013) Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr 172(3):343–349. doi:10.​1007/​s00431-012-1891-5 CrossRefPubMed
7.
go back to reference Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, Sonobe T, Nakamura Y (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171(4):651–656. doi:10.1007/s00431-011-1630-3 CrossRefPubMed Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, Sonobe T, Nakamura Y (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171(4):651–656. doi:10.​1007/​s00431-011-1630-3 CrossRefPubMed
8.
go back to reference Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G (2015) Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Rheumatol Int 35(6):1053–1058. doi:10.1007/s00296-014-3186-9 CrossRefPubMed Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G (2015) Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Rheumatol Int 35(6):1053–1058. doi:10.​1007/​s00296-014-3186-9 CrossRefPubMed
Metadata
Title
A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease?
Authors
Pandiarajan Vignesh
Sagar Bhattad
Manphool Singhal
Surjit Singh
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2016
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3490-7

Other articles of this Issue 8/2016

Rheumatology International 8/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.